Cetera Advisor Networks’s Tandem Diabetes Care TNDM Stock Holding History

Cetera Advisor Networks’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,050	Closed	-$368K	–	2719
2023 Q1	$368K	Sell	9,050 -1,000	-10%	-$41.4K	﹤0.01%	1903
2022 Q4	$452K	Sell	10,050 -2,756	-22%	-$125K	﹤0.01%	1713
2022 Q3	$613K	Sell	12,806 -965	-7%	-$52.9K	0.01%	1157
2022 Q2	$815K	Buy	13,771 +353	+3%	+$29K	0.01%	983
2022 Q1	$1.56M	Sell	13,418 -685	-5%	-$80K	0.02%	720
2021 Q4	$2.12M	Sell	14,103 -183	-1%	-$24.7K	0.03%	582
2021 Q3	$1.71M	Buy	14,286 +3,165	+28%	+$349K	0.02%	608
2021 Q2	$1.08M	Buy	+11,121	New	+$992K	0.02%	796
2020 Q3	–	Sell	-1,532	Closed	-$152K	–	2868
2020 Q2	$152K	Buy	+1,532	New	+$122K	﹤0.01%	1264
2018 Q2	–	Sell	-23,500	Closed	-$117K	–	913
2018 Q1	$117K	Buy	+23,500	New	+$75.8K	0.01%	828

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Cetera Advisor Networks's TNDM Position: Q2 2023 in Review

Cetera Advisor Networks sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 9,050 shares — an estimated $368K sold.

Cetera Advisor Networks first reported a position in TNDM in Q1 2018 and held it in 10 quarters. The position peaked at $2.12M in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Cetera Advisor Networks reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Cetera Advisor Networks sold 9,050 Tandem Diabetes Care shares in Q2 2023, an estimated $368K.
Cetera Advisor Networks first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 10 quarters.
Cetera Advisor Networks's Tandem Diabetes Care position peaked at $2.12M in Q4 2021.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.